HomeInsightsStock Comparison

Mangalam Drugs And Organics Ltd vs Zydus Lifesciences Ltd Stock Comparison

Mangalam Drugs And Organics Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 86.15 as of 16 Jul 15:15.
  • The P/E Ratio of Mangalam Drugs and Organics Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 26.2 on March 2024 to 25.4 on March 2023 . This represents a CAGR of -0.62% over 5 years.
  • The Market Cap of Mangalam Drugs and Organics Ltd changed from ₹ 146.65 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 101151 crore on March 2024 to ₹ 49749 crore on March 2023 . This represents a CAGR of -13.23% over 5 years.
  • The revenue of Mangalam Drugs and Organics Ltd for the Mar '25 is ₹ 73.25 crore as compare to the Dec '24 revenue of ₹ 88.85 crore. This represent the decline of -17.56% The revenue of Zydus Lifesciences Ltd for the Mar '25 is ₹ 6608 crore as compare to the Dec '24 revenue of ₹ 5326 crore. This represent the growth of 24.07%.
  • The ebitda of Mangalam Drugs and Organics Ltd for the Mar '25 is ₹ 10.37 crore as compare to the Dec '24 ebitda of ₹ 8.91 crore. This represent the growth of 16.39% The ebitda of Zydus Lifesciences Ltd for the Mar '25 is ₹ 1986 crore as compare to the Dec '24 ebitda of ₹ 1444 crore. This represent the growth of 37.49%.
  • The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 0.5 crore to ₹ 0.06 crore over 8 quarters. This represents a CAGR of -65.36% The net profit of Zydus Lifesciences Ltd changed from ₹ 733.5 crore to ₹ 1248 crore over 8 quarters. This represents a CAGR of 30.48% .
  • The Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 8.77 % on March 2024 . This represents a CAGR of -19.14% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Mangalam Drugs and Organics Ltd News Hub

News

Mangalam Drugs and Organics schedules EGM

Mangalam Drugs and Organics announced that an Extra Ordinary General Meeting (EGM) of the ...

Read more

14 Jul 2025 10:27

News

Mangalam Drugs and Organics announces board meeting date

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

15 May 2025 15:37

News

Mangalam Drugs and Organics to conduct board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

05 Apr 2025 10:36

News

Mangalam Drugs and Organics to convene board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

06 Feb 2025 16:48

News

Mangalam Drugs and Organics receives upgrade in credit ratings from CRISIL

Mangalam Drugs and Organics has received upgrade in credit ratings from CRISIL as under: L...

Read more

16 Jan 2025 14:54

News

Mangalam Drugs and Organics Ltd leads gainers in 'B' group

Soma Textiles & Industries Ltd, Saraswati Saree Depot Ltd, Pudumjee Paper Products Ltd and...

Read more

29 Nov 2024 12:15

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences gets USFDA Nod for Celecoxib Capsules

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones ...

Read more

15 Jul 2025 15:45

News

Zydus Life Matoda facility receives two observations from USFDA after inspection

In a regulatory filing, the company confirmed that the USFDA conducted a follow-up inspect...

Read more

19 Jun 2025 09:50

News

Zydus Lifesciences appoints Managing Director

Zydus Lifesciences has approved the appointment of s. Swati Dalal as the Additional Direct...

Read more

16 Jun 2025 14:16

News

Zydus Life subsidiary ZHL appoints Swati Dalal as MD

The appointment was approved by the nomination and remuneration committee (NRC). Swati Dal...

Read more

16 Jun 2025 14:42

News

Zydus Life receives USFDA EIR for Gujarat facility

The inspection was conducted by the USFDA from March 10 to March 14, 2025. Following the r...

Read more

12 Jun 2025 09:55

News

Zydus' Ankleshwar API unit clears USFDA inspection

Zydus Lifesciences has received the Establishment Inspection Report (EIR) report from the ...

Read more

12 Jun 2025 10:41

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mangalam Drugs and Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mangalam Drugs and Organics Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Mangalam Drugs and Organics Ltd or Zydus Lifesciences Ltd?

Market cap of Mangalam Drugs and Organics Ltd is 136 Cr while Market cap of Zydus Lifesciences Ltd is 97,317 Cr

What are the key factors driving the stock performance of Mangalam Drugs and Organics Ltd and Zydus Lifesciences Ltd?

The stock performance of Mangalam Drugs and Organics Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Drugs and Organics Ltd and Zydus Lifesciences Ltd?

As of July 16, 2025, the Mangalam Drugs and Organics Ltd stock price is INR ₹86.34. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹967.15.

How do dividend payouts of Mangalam Drugs and Organics Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Mangalam Drugs and Organics Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions